Literature DB >> 4060104

Effect of danazol on the biochemical abnormality of inherited antithrombin III deficiency.

A J Fairfax, R M Ibbotson.   

Abstract

Seven members of a family affected by hereditary antithrombin III deficiency were identified. The disorder was associated with recurrent spontaneous episodes of phlebitis, deep venous thrombosis, and pulmonary embolism in middle age. Danazol, a 17-alkyl derivative of ethinyl testosterone, which has been used to treat other antiprotease deficiency states, was assessed in the management of two men with antithrombin deficiency. In a dose of 600 mg a day danazol appeared to correct the antithrombin deficiency. This drug may provide a useful adjunct to anticoagulant treatment, particularly before surgery.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4060104      PMCID: PMC460163          DOI: 10.1136/thx.40.9.646

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  14 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  Oral contraceptives and low antithrombin-3 concentration.

Authors:  M K Fagerhol; U Abildgaard; P Bergsjo; J H Jacobsen
Journal:  Lancet       Date:  1970-05-30       Impact factor: 79.321

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Molecular heterogeneity of inherited antithrombin III deficiency.

Authors:  E V Prochownik; S Antonarakis; K A Bauer; R D Rosenberg; E R Fearon; S H Orkin
Journal:  N Engl J Med       Date:  1983-06-30       Impact factor: 91.245

Review 5.  Structure and variation of human alpha 1-antitrypsin.

Authors:  R W Carrell; J O Jeppsson; C B Laurell; S O Brennan; M C Owen; L Vaughan; D R Boswell
Journal:  Nature       Date:  1982-07-22       Impact factor: 49.962

6.  Antithrombin III deficiency, hypertriglyceridaemia, and venous thromboses.

Authors:  O H Gyde; M D Middleton; G R Vaughan; D J Fletcher
Journal:  Br Med J       Date:  1978-03-11

7.  Stanazolol treatment in an AT III deficient patient.

Authors:  J N Fiessinger; M Aiach
Journal:  Thromb Haemost       Date:  1980-06-18       Impact factor: 5.249

8.  Familial antithrombin III deficiency.

Authors:  J H Winter; A Fenech; W Ridley; B Bennett; A M Cumming; M Mackie; A S Douglas
Journal:  Q J Med       Date:  1982

9.  Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.

Authors:  J E Gadek; J D Fulmer; J A Gelfand; M M Frank; T L Petty; R G Crystal
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

10.  Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease.

Authors:  H R Gralnick; M E Rick
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.